Literature DB >> 18097527

Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study.

Stephanie T Page1, Beth A Mohr, Carol L Link, Amy B O'Donnell, William J Bremner, John B McKinlay.   

Abstract

AIM: To study the relationship between circulating androgens (total testosterone [TT], free testosterone [fT] and dihydrotestosterone [DHT]) and high-density lipoprotein cholesterol (HDL-C) in men with and without cardiovascular disease (CVD).
METHODS: Cross-sectional analyses included 1 661 baseline samples from the Massachusetts Male Aging Study (MMAS), a population-based cohort of men ages 40-70 years. Serum hormones were measured by radioimmunoassay and HDL-C was determined following precipitation of the lower density lipoproteins. CVD was determined by self-report. Analyses were performed using multiple linear regression.
RESULTS: TT and HDL-C were positively correlated in the entire sample (r=0.11, P=0.0001). After adjusting for confounders, we found this relationship was mostly limited to the 209 men with CVD. Among men with CVD, TT (P=0.0004), fT (P=0.0172) and DHT (P=0.0128) were all positively correlated with HDL-C, whereas in men without CVD only TT correlated with HDL-C (P=0.0099).
CONCLUSION: Our results suggest that if androgens contribute to CVD in middle-aged men, the effect is not related to a suppressive effect of endogenous T on HDL-C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097527      PMCID: PMC2666971          DOI: 10.1111/j.1745-7262.2008.00332.x

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  26 in total

1.  Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels.

Authors:  R T Kirkland; B S Keenan; J L Probstfield; W Patsch; T L Lin; G W Clayton; W Insull
Journal:  JAMA       Date:  1987 Jan 23-30       Impact factor: 56.272

2.  Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.

Authors:  M Ozata; M Yildirimkaya; M Bulur; K Yilmaz; E Bolu; A Corakci; M A Gundogan
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

3.  Sex hormones and lipoproteins in men.

Authors:  D P Kiel; J A Baron; S R Plymate; C G Chute
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965

4.  Physical activity assessment methodology in the Five-City Project.

Authors:  J F Sallis; W L Haskell; P D Wood; S P Fortmann; T Rogers; S N Blair; R S Paffenbarger
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

5.  Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study.

Authors:  J W Yarnell; A D Beswick; P M Sweetnam; D Riad-Fahmy
Journal:  Arterioscler Thromb       Date:  1993-04

6.  Lifetime risk of developing coronary heart disease.

Authors:  D M Lloyd-Jones; M G Larson; A Beiser; D Levy
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

7.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Authors:  P Jousilahti; E Vartiainen; J Tuomilehto; P Puska
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

Review 8.  Testosterone and risk factors for cardiovascular disease in men.

Authors:  E L Barrett-Connor
Journal:  Diabete Metab       Date:  1995-06

9.  High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use.

Authors:  B F Hurley; D R Seals; J M Hagberg; A C Goldberg; S M Ostrove; J O Holloszy; W G Wiest; A P Goldberg
Journal:  JAMA       Date:  1984-07-27       Impact factor: 56.272

10.  Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.

Authors:  E Barrett-Connor; K T Khaw
Journal:  Circulation       Date:  1988-09       Impact factor: 29.690

View more
  6 in total

Review 1.  Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis.

Authors:  Andre B Araujo; Julia M Dixon; Elizabeth A Suarez; M Hassan Murad; Lin T Guey; Gary A Wittert
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

2.  Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet.

Authors:  F Cadario; F Prodam; S Pasqualicchio; S Bellone; I Bonsignori; I Demarchi; A Monzani; G Bona
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

Review 3.  A practical guide to male hypogonadism in the primary care setting.

Authors:  P Dandona; M T Rosenberg
Journal:  Int J Clin Pract       Date:  2010-05       Impact factor: 2.503

Review 4.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

5.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

6.  A cross-sectional study of the association of age, race and ethnicity, and body mass index with sex steroid hormone marker profiles among men in the National Health and Nutrition Examination Survey (NHANES III).

Authors:  Jamie Ritchey; Wilfried Karmaus; Tara Sabo-Attwood; Susan E Steck; Hongmei Zhang
Journal:  BMJ Open       Date:  2012-10-06       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.